Dr Lal Pathlabs Ltd Financials

Dr Lal Pathlabs Ltd Financial Statement

Dr Lal Pathlabs Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Mar 2025	Dec 2024	Sep 2024
Revenue	602.40	600.50	605.90
Operating Expense	418.10	418.20	399.40
Net Profit	148.40	105.40	135.20
Net Profit Margin	24.63	17.55	22.31
Earning Per Share	17.80	12.65	16.24
EBIDTA	225.80	181.50	202.60
Effective Tax Rate	20.62	20.52	21.40

Particulars	Mar 2025
Revenue	602.40
Operating Expense	418.10
Net Profit	148.40
Net Profit Margin	24.63
Earning Per Share	17.80
EBIDTA	225.80
Effective Tax Rate	20.62

Dr Lal Pathlabs Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	1,966.76	1,769.03	1,878.79
Operating Expenses Annual	1,407.52	1,308.33	1,366.32
Operating Profit Annual	619.35	507.30	565.57
Interest Annual	26.84	34.38	28.63
Depreciation	39.21	40.60	35.38
Net Profit Annual	384.37	292.36	345.25
Tax Annual	131.60	98.47	115.74

Particulars	Mar 2024
Total Revenue Annual	1,966.76
Operating Expenses Annual	1,407.52
Operating Profit Annual	619.35
Interest Annual	26.84
Depreciation	39.21
Net Profit Annual	384.37
Tax Annual	131.60

Dr Lal Pathlabs Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	220.32	351.31	232.87
Cash Flow from Operations	477.60	427.53	425.73
Cash Flow from Investing	31.91	-288.47	-448.53
Cash Flow from Financing	-404	-270.05	141.24
Cash Flow at the End	325.83	220.32	351.31

Particulars	Mar 2024
Cash Flow at the Beginning	220.32
Cash Flow from Operations	477.60
Cash Flow from Investing	31.91
Cash Flow from Financing	-404
Cash Flow at the End	325.83

Dr Lal Pathlabs Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	31.49	28.68	30.10
PBIT Margin (%)	27.60	24.04	26.06
PBT Margin (%)	26.57	23.34	25.15
Net PROFIT Margin (%)	19.54	16.53	18.38
Return On Networth / Equity (%)	21.42	18.49	25.68
Return On Networth /Employed (%)	25.77	20.93	29.35
Return On Assets (%)	18.18	14.38	20.77
Total Debt / Equity (X)	0.12	0.21	0.16
Asset Turnover Ratio (%)	0.93	0.87	1.13

Particulars	Mar 2024
PBDIT Margin (%)	31.49
PBIT Margin (%)	27.60
PBT Margin (%)	26.57
Net PROFIT Margin (%)	19.54
Return On Networth / Equity (%)	21.42
Return On Networth /Employed (%)	25.77
Return On Assets (%)	18.18
Total Debt / Equity (X)	0.12
Asset Turnover Ratio (%)	0.93

Dr Lal Pathlabs Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	310.67	363.45	370.95
Total Current Assets Annual	920.55	810.17	699.31
Non Current Assets Annual	1,494.89	1,510.00	1,511.47
Total Shareholders Funds Annual	1,899.66	1,689.86	1,472.12
Total Assets Annual	2,415.44	2,320.17	2,210.78

Particulars	Mar 2024
Fixed Assets Annual	310.67
Total Current Assets Annual	920.55
Non Current Assets Annual	1,494.89
Total Shareholders Funds Annual	1,899.66
Total Assets Annual	2,415.44

Dr Lal Pathlabs Ltd Earning Calls

EPS (INR)

Expected

18.52

Reported

18.57

Surprise

0.27%

Dec 2024

EPS beaten by 0.27%

Sep 2024

EPS beaten by 0.26%

Jun 2024

EPS beaten by 0.45%

Dividend Pages

PE Ratio

FAQS on Dr Lal Pathlabs Ltd Financials

As of May 6, 2025, Dr Lal Pathlabs Ltd has a market capitalization of 20,714.87 Cr. Value Research classifies it as a Large-Cap company.

Yes, Dr Lal Pathlabs Ltd is debt-free with a debt-to-equity ratio of 0.07.

In FY 2024 , Dr Lal Pathlabs Ltd recorded a total revenue of approximately 2,351.60 Cr marking a significant milestone in the company's financial performance.

Dr Lal Pathlabs Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and 0.1% annually, respectively..

Dr Lal Pathlabs Ltd's current PE ratio is 41.65.

Dr Lal Pathlabs Ltd's ROCE averaged 24.5% from the FY ending March 2023 to 2025, with a median of 25.0%. It peaked at 28.1% in March 2025, reflecting strong capital efficiency over the period..

Dr Lal Pathlabs Ltd's latest EBIT is Rs. 642.80 Cr, surpassing the average EBIT of Rs. 526.37 Cr over the 5 years..